BACKGROUND For standardising of multiparametric magnetic resonance (MR) imaging of the prostate, the European Society of Urogenital Radiology published Prostate Imaging Reporting and Data System (PI-RADS) in 2012. 1,2 Later it was validated and the PI-RADS sum score for summation of the single score for the three different pulse sequences (T2-weighted imaging, diffusion-weighted imaging [DWI] and dynamic contrast material-enhanced [DCE] was being used. MRI has an emerging role in facilitating the diagnosis of prostatic malignancy. The purpose of the present study was to correlate the results of TRUS-guided targeted prostate biopsy with the PI-RADS scoring (Version 2) on MP-MRI in patients, wherein prostatic malignancy has been suspected.